Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-26 @ 2:06 AM
NCT ID:
NCT00622505
Group ID:
EG001
Title:
Zoledronic Acid Every 4 Weeks or 12 Weeks
Description:
Participants received 4 mg or a reduced dose, i.e., 3.5 mg, or 3.3 mg or 3.0 mg of Zoledronic acid as an IV infusion over a minimum of 15 minutes every 4 weeks or every 12 weeks for up to 96 weeks based on the participants most recent urine NTx measurement (≥ 50 nmol/mmol creatinine or \<50 nmol/mmol creatinine, respectively).
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
25
Serious Number At Risk:
42
Other Number Affected:
41
Other Number At Risk:
42
Study:
NCT00622505
Results Section:
NCT00622505
Adverse Events Module:
NCT00622505